In May when AJ Gallagher confirmed this publication's prior reporting that it had struck a deal to buy a basket of remedy assets from Willis Towers Watson, my colleagues on the Inside P&C research team described it as "manna...
In May when AJ Gallagher confirmed this publication's prior reporting that it had struck a deal to buy a basket of remedy assets from Willis Towers Watson, my colleagues on the Inside P&C research team described it as "manna...